Jeewoo Kim
Has grant
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Recent Grants
Grant: Close
Vanderbilt’s Clinical and Translational Award
Open Date: 2023-08-01
Close Date:
Articles (4)
Uterine leiomyomata or fibroids are highly heritable, common, and benign tumors of the uterus with poorly understood etiology. Previous GWAS have reported 72 associated genes but included limited numbers of non-European individuals. Here, we identify 11 novel genes associated with fibroids across multi-ancestry and ancestry-stratified GWAS analyses. We replicate a known fibroid GWAS gene in African ancestry individuals and estimate the SNP-based heritability of fibroids in African ancestry populations as 15.9%. Using genetically predicted gene expression and colocalization analyses, we identify 46 novel genes associated with fibroids. These genes are significantly enriched in cancer, cell death and survival, reproductive system disease, and cellular growth and proliferation networks. We also find that increased predicted expression of HEATR3 in uterine tissue is associated with fibroids across ancestry strata. Overall, we report genetic variants associated with fibroids coupled with functional and gene pathway enrichment analyses.
Year:
2025
Many complex traits in humans exhibit sex differences. Recent advances in understanding context-specific genetic effects underscore the imperative for sex-aware genetic analyses to assess the role of sex in the genetic basis of human phenotypes. Despite increasing recognition of the importance of sex as a biological variable, current computational tools for genome-wide association studies (GWAS) lack functionality for performing nuanced sex-aware quality control and analysis. In response, we present GXwasR, a comprehensive R package that implements statistical genetic models for performing both GWAS and X-Chromosome-Wide Association Studies (XWAS). Designed for both sex-combined and sex-stratified analyses, GXwasR can account for unique features of chromosome X, including X-chromosome inactivation. Beyond enabling association analysis and meta-analysis, the tool has functions to a) test for sex differences in SNP-level genetic effects and heritability, b) assess genetic correlation, c) compute sex-aware polygenic risk scores (PRS), and d) support enhanced quality control protocols expressly designed for these purposes. GXwasR thus serves as a computational resource to enable investigations into the role of sex in the genetic basis of complex human phenotypes.
Year:
2025
Identification of drug-repurposing targets with genetic and biological support is an economically and temporally efficient strategy for improving treatment of diseases. We employed a cross-disciplinary approach to identify potential treatments for metabolic dysfunction associated steatotic liver disease (MASLD) using humans as a model organism. We identified 212 putative causal genes associated with MASLD using data from a large multi-ancestry genetic association study, of which 158 (74.5%) are novel. From this set we identified 57 genes that encode for druggable protein targets, and where the effects of increasing genetically predicted gene expression on MASLD risk align with the function of that drug on the protein target. These potential targets were then evaluated for evidence of efficacy using Mendelian randomization, pathway analysis, and protein structural modeling. Using these approaches, we present compelling evidence to suggest activation of FADS1 by icosopent ethyl as well as S1PR2 by fingolimod could be promising therapeutic strategies for MASLD.
Year:
2025
Diseases such as uterine leiomyomata (fibroids and benign tumors of the uterus) and keloids (raised scars) may share common etiology. Fibroids and keloids can co-occur in individuals, and both are highly heritable, suggesting they may share common genetic risk factors. Fibroproliferative diseases are common and characterized by scarring and overgrowth of connective tissue, impacting multiple organ systems. These conditions both have racial disparities in prevalence, with the highest prevalence observed among individuals of African ancestry. Several fibroproliferative diseases are more severe and common in populations of sub-Saharan Africa. This mini-review aims to provide a broad overview of the current knowledge of the evolutionary origins and causes of fibroproliferative diseases. We also discuss current hypotheses proposing that the increased prevalence of these diseases in African-derived populations is due to the selection for profibrotic alleles that are protective against helminth infections and provide examples from knowledge of uterine fibroid and keloid research.
Year:
2023
Collaborators (15)
Laura Rasmussen-Torvik
Professor and Division Chief, Epidemiology
Northwestern University Feinberg School of Medicine
Digna R. Velez Edwards
Vanderbilt University Medical Center
Ariel Williams
Assistant Professor
University of Virginia Health System
Adam Bress
Research Assistant Professor
University of Utah
Jacklyn N. Hellwege
Vanderbilt University Medical Center
Barbara Stranger
Associate Professor
Northwestern University Feinberg School of Medicine
Marijana Vujkovic
Research Assistant Professor
University of Pennsylvania
Lea Davis
Professor
Vanderbilt University
Michael Levin
Cardiologist
Corporal Michael J. Crescenz VA Medical Center
Megan M Shuey
Vanderbilt University Medical Center
Dipender Gill
Imperial College London
Jens Meiler
Vanderbilt University
Edward A. Ruiz-Narváez
Associate Professor
University of Michigan School of Public Health
Maria Niarchou
Senior Scientist
Vanderbilt University Medical Center
Kyong-Mi Chang
Professor of Medicine & Associate Chief of Staff for R&D
University of Pennsylvania
Make your next move.
Prepare your application
Review drafts before you send them.